SGM-101 in Colorectal Brain Metastases.

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Rectal NeoplasmsRectum CancerColorectal NeoplasmsBrain MetastasesBrain NeoplasmsBrain DiseasesBrain CancerBrain TumorIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal CancerGastrointestinal DiseaseIntestinal Disease
Interventions
DRUG

SGM-101

Fluorescence-guided surgery

Trial Locations (2)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

2512 VA

RECRUITING

Medical Center Haaglanden, The Hague

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Center Haaglanden

OTHER

collaborator

Surgimab

INDUSTRY

lead

Leiden University Medical Center

OTHER